The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation

Transplantation

Volumn 87, Issue 11, 2009, Pages 1645-1653

  Ogawa, Masahito ^a,b   Suzuki, Jun Ichi ^a,b   Kosuge, Hisanori ^a   Takayama, Kiyoshi ^c   Nagai, Ryozo ^b   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NB Health Laboratory   (Japan)

Author keywords

Inflammation; Macrophages; Transcriptional factors; Transplantation

Indexed keywords

17,18,19,20 TETRANOR 16 (3 BIPHENYL) 2,3,13,14 TETRAHYDROPROSTAGLANDIN E1; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; FTA 2062; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART GRAFT; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE ACTIVATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

ALPROSTADIL; ANIMALS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LYMPH NODES; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; NF-KAPPA B; POLYMERASE CHAIN REACTION; RECEPTORS, PROSTAGLANDIN E; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 67649610602     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a5c84c     Document Type: Article

References (44)

1. Needleman P, Turk J, Jakschik BA, et al. Arachidonic acid metabolism. Annu Rev Biochem 1986; 55: 69.
2. Wang M, Zukas AM, Hui Y, et al. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci USA 2006; 103: 14507.
3. Degousee N, Fazel S, Angoulvant D, et al. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation 2008; 117: 1701.
4. Tilley SL, Coffman TM, Koller BH. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15.
5. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146: 108.
6. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46: 205.
7. Southall MD, Vasko MR. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 2001; 276: 16083.
8. Takayama K, Garcia-Cardena G, Sukhova GK, et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002; 277: 44147.
9. Nataraj C, Thomas DW, Tilley SL, et al. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest2001; 108: 1229.
10. Morichika T, Takahashi HK, Iwagaki H, et al. Effect of prostaglandin E2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction. Transplantation 2003; 75: 2100.
11. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult heart transplant report-2005. J Heart Lung Transplant2005; 24: 945.
12. Isobe M, Yagita H, Okumura K, et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science1992; 255: 1125.
13. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109(suppl): S81.
14. Takahashi N, Tetsuka T, Uranishi H, et al. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur J Biochem 2002; 269: 4559.
15. Nomi T, Sho M, Akahori T, et al. Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. Transplant Proc 2006; 38: 3209.
16. Hishikari K, Suzuki J, Ogawa M, et al. Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischemia/reperfusion injury. Cardiovasc Res 2009; 81: 123.
17. Wakatsuki S, Suzuki J, Ogawa M, et al. A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration. Expert Opin Ther Targets 2008; 12: 1469.
18. Kosuge H, Suzuki J, Gotoh R, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation2003; 75: 1374.
19. Suzuki J, Ogawa M, Sagesaka YM, et al. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc Res 2006; 69: 272.
20. Ogawa M, Suzuki J, Hishikari K, et al. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008; 51: 1977.
21. Trifan O, Durham W, Salazar V, et al. Cyclooxygenase-2 inhibitor with Celecoxib enhances anti-tumor efficacy and reduces diarrhea side effect of CRT-11. Cancer Res 2002; 62: 5778.
22. Gunzer M, Weishaupt C, Planelles L, et al. Two-step negative enrichment of CD4- and CD8- T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail. J Immunol Methods 2001; 258: 55.
23. Chen BC, Lin WW. Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase. Br J Pharmacol 2000; 130: 777.
24. Roach TI, Chatterjee D, Blackwell JM. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: Regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun 1994; 62: 1176.
25. Gerlo S, Verdood P, Gellersen B, et al. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: Cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calciumand cyclic adenosine 5-monophosphate-mediated signaling pathways. J Immunol 2004; 173: 5952.
26. Renard P, Ernest I, Houbion A, et al. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 2001; 29: E21.
27. Ogawa M, Suzuki J, Koga N, et al.Aspecific COX-2 inhibitor attenuates cell infiltration but does not prolong graft survival in murine cardiac transplantation. Transplant Proc 2005; 37: 121.
28. Milton AD, Fabre JW. Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat. J Exp Med 1985; 161: 98.
29. Ascher NL, Ferguson RM, Hoffman R, et al. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation1979; 27: 254.
30. Isobe M, Suzuki J. New approaches to the management of acute and chronic cardiac allograft rejection. Jpn Circ J 1998; 62: 315.
31. Mazzarella G, Petillo O, Margarucci S, et al. Role of monocyte/macrophage population in immune response. Monaldi Arch Chest Dis 1998; 53: 92.
32. Bloom D, Jabrane-Ferrat N, Zeng L, et al. Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. Cell Immunol 1999; 194: 21.
33. Kuroda E, Yamashita U. Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 2003; 170: 757.
34. Hsieh CS, Macatonia SE, Tripp CS, et al. Development of TH1 CD4- T cells through IL-12 produced by Listeria-induced macrophages. Science1993; 260: 547.
35. Manetti R, Gerosa F, Giudizi MG, et al. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med 1994; 179: 1273.
36. Seder RA, Gazzinelli R, Sher A, et al. Interleukin 12 acts directly on CD4- T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188.
37. Takayama K, Sukhova GK, Chin MT, et al. A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circ Res 2006; 98: 499.
38. Tomura K, Narumi S. Differential induction of interferon (IFN)- inducible protein 10 following differentiation of a monocyte, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites. Int J Mol Med 1999; 3: 477.
39. Ueda A, Okuda K, Ohno S, et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153: 2052.
40. Widmer U, Manogue KR, Cerami A, et al. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J Immunol 1993; 150: 4996.
41. Bastien L, Sawyer N, Grygorczyk R, et al. Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J Biol Chem 1994; 269: 11873.
42. Kazanietz MG, Enero MA. Decreased beta-adrenoceptor-mediated vasodilation in aorta from aged rats: Possible involvement of a stimulatory GTP-binding protein. Eur J Pharmacol 1991; 198: 177.
43. Malek S, Huxford T, Ghosh G. Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. J Biol Chem 1998; 273: 25427.
44. Minami M, Shimizu K, Okamoto Y, et al. Prostaglandin E receptor type 4-associated protein interacts directly with NF-{kappa}B1 and attenuates macrophage activation. J Biol Chem 2008; 283: 9692.